Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Nanologica AB ( (SE:NICA) ) is now available.
Nanologica AB announced a change in the number of registered shares and votes following the exercise of warrants of series TO5, resulting in an increase to 88,369,820 shares. This adjustment in share capital reflects the company’s ongoing financial activities and may impact its market positioning and stakeholder interests as it continues to expand its operations in the pharmaceutical consumables market.
More about Nanologica AB
Nanologica AB is a Swedish life science tools company that specializes in developing, manufacturing, and selling advanced consumables for pharmaceutical manufacturers. The company’s products are designed for the purification of peptide drugs, such as insulin and GLP-1 analogues, which help increase productivity and reduce costs for pharmaceutical manufacturers. Operating in a growing global niche market driven by the demand for diabetes and obesity treatments, Nanologica aims to enhance access to cost-effective drugs worldwide.
YTD Price Performance: -37.64%
Average Trading Volume: 358,045
Current Market Cap: SEK100.3M
See more insights into NICA stock on TipRanks’ Stock Analysis page.